{"id":7213,"name":"Lexi Ventures","slug":"lexi-ventures","website":"https://www.lexi.vc/","hqGeo":null,"stageFocus":[],"sectorTags":[],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":null,"thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Kopra Bio","companyUrl":null,"stage":null,"sector":"Immunotherapy","investmentYear":null,"description":"Engineering T-cells to eradicate solid tumors without viral vectors.","amountUsd":null,"relevanceNote":null,"fundName":"Lexi Ventures Fund I LP"},{"companyName":"ParcelBio","companyUrl":null,"stage":null,"sector":"RNA Delivery","investmentYear":null,"description":"A programmable 'postal service' for mRNA, targeting tissues with 99% accuracy.","amountUsd":null,"relevanceNote":null,"fundName":"Lexi Ventures Fund I LP"},{"companyName":"KiraGen","companyUrl":null,"stage":null,"sector":"Gene Editing","investmentYear":null,"description":"High-fidelity CRISPR tools designed for safer, rapid clinical translation.","amountUsd":null,"relevanceNote":null,"fundName":"Lexi Ventures Fund I LP"},{"companyName":"QUiCKR Bio","companyUrl":null,"stage":null,"sector":"Tools","investmentYear":null,"description":"The quality control layer for gene editing—quantifying safety and off-target effects.","amountUsd":null,"relevanceNote":null,"fundName":"Lexi Ventures Fund I LP"},{"companyName":"Melio","companyUrl":null,"stage":null,"sector":"Diagnostics","investmentYear":null,"description":"Rapid, life-saving pathogen diagnostics for newborns and critical care.","amountUsd":null,"relevanceNote":null,"fundName":"Lexi Ventures Fund I LP"},{"companyName":"AlkaLi Labs","companyUrl":null,"stage":null,"sector":"Industrial Bio","investmentYear":null,"description":"Biomining platform using microbes to harvest critical minerals from industrial brine.","amountUsd":null,"relevanceNote":null,"fundName":"Lexi Ventures Fund I LP"},{"companyName":"Glyphic Bio","companyUrl":null,"stage":null,"sector":"Proteomics","investmentYear":null,"description":"Next-generation single-molecule protein sequencing to decode the proteome.","amountUsd":null,"relevanceNote":null,"fundName":"Lexi Ventures Fund I LP"},{"companyName":"Syntensor","companyUrl":null,"stage":null,"sector":"Computational Bio","investmentYear":null,"description":"AI simulation platform predicting clinical trial outcomes and metabolic pathways.","amountUsd":null,"relevanceNote":null,"fundName":"Lexi Ventures Fund I LP"},{"companyName":"TippingPoint","companyUrl":null,"stage":null,"sector":"Therapeutics","investmentYear":null,"description":"Precision genetic medicines targeting rare and neglected pediatric diseases.","amountUsd":null,"relevanceNote":null,"fundName":"Lexi Ventures Fund I LP"},{"companyName":"Taxa","companyUrl":null,"stage":null,"sector":"Consumer Bio","investmentYear":null,"description":"Bio-engineered consumer products, starting with the world's first active probiotic skincare.","amountUsd":null,"relevanceNote":null,"fundName":"Lexi Ventures Fund I LP"},{"companyName":"Crank Bio","companyUrl":null,"stage":null,"sector":"Rare Disease","investmentYear":null,"description":"RNA based antisense therapeutics for rare genetic diseases.","amountUsd":null,"relevanceNote":null,"fundName":"Lexi Ventures Fund I LP"}],"partnerCount":1,"partners":[{"id":18659,"name":"Jonah Probell","title":"General Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":"Before founding Lexi Ventures, Jonah held founder, executive, and engineering roles in 7 startups over 25 years. He achieved 2 IPOs, 16 granted patents and wrote 2 books. He has a lifelong interest in science, engineering, economics, philosophy, and innovation.","recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[],"contentUpdatedAt":null,"investorType":"vc","preferredApproach":null,"prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[],"featuredIn":[],"fundraisingResources":[{"slug":"how-to-find-investors","title":"How to Find Investors: A VC's Playbook for Founders"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-09-01T15:01:30.618Z"}